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 1 
INTRODUCTION / BACKGROUND 
 Stress Urinary Incontinence is defined as the involuntary loss of 
urine from the urethra during physical activities that increase the intra 
abdominal pressure in the absence of detrusor activity. It is the major 
proportion of cause of urinary incontinence. SUI can develop through two 
mechanisms; hyper mobility - significant displacement of the urethra and 
bladder neck during exertion and intrinsic sphincter 
deficiency(ISD).These two conditions can coexist in women. 
 As stated by the American Urologic Association consensus 
statement in 2001, there are only 2 procedures that are proven to have 
effective long-term cure rates for the treatment of stress urinary 
incontinence (SUI). These procedures are the abdominal Burch 
Colposuspension     and the sling procedure that is completed vaginally. 
 However, in the past, the sling procedure was far from 
standardized. There have been multiple different descriptions using 
different materials for the sling (fascia from the patient, cadaveric fascia 
or dermis from humans or animals, synthetics, etc), different anchoring    
points, and different methods to adjust the tension of the sling. In many 
cases patients had to undergo general anesthesia, were in the hospital for 
several days, required a catheter to drain the bladder and many patients 
suffered high rates of voiding dysfunction following these slings.         
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 However the introduction of the tension-free vaginal tape 
procedures to the United States in the late 90’s revolutionized the 
treatment of SUI. It introduced a standardized sling procedure that could 
be completed safely in 20 minutes under local anesthesia, utilizing 3 very 
small incisions with minimal dissection, a cough test for individual  
tension   patient  adjustment and excellent cure rates. Over 500,000 of 
these procedures have been  completed  worldwide. 
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AIM OF STUDY 
To study the efficacy of TOT in Stress Urinary Incontinence 
To analyse immediate and late complications 
Compare the results 
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REVIEW OF LITERATURE 
 The prevalence of incontinence may be significantly 
underestimated since physicians rarely ask patients about the problem and 
the patients seldom initiate discussion about incontinence with the 
physician. Older patients may assume that urinary incontinence is a 
normal consequence of aging. The prevalence of urinary incontinence in 
a community is as high as 30%  Some patients do not disclose the 
incontinence because of fear of invasive testing. Incontinence may be 
genuine stress incontinence, detrusor instability or mixed incontinence. 
DIAPPERS - (Delirium, Infection, Atrophic urethritis / vaginitis, 
Restricted mobility and Stool impaction) summarizes the functional 
causes. The inability to control the urine is most unpleasant and 
distressing problem. Incontinence does not lead to death but it causes 
substantial debility, social seclusion, psychological stress, and 
economical burden. Although involuntary loss of urine is not a normal 
part of ageing, it often becomes a clinical problem for the ageing women 
due to trauma of child birth, development of acute and chronic illnesses, 
loss of estrogenic stimulation at menopause, weaker pelvic support, and 
diminished amount of normal homeostatic reserve available to cope with 
stresses placed on the bladder. 
 Since the inception of the pubovaginal sling approximately a 
century ago, experimentation has continued with multiple types of slings 
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composed of different materials using different suspension techniques. 
Materials used as sling constituents have included autografts, allografts, 
xenografts, and, more recently, synthetic variants. Methods of anchoring 
these slings have also undergone development and advancement; 
however, the ideal method of suspension remains to be completely 
defined. Sling placement was classically described at the level of the 
bladder neck in an effort to correct urethral hypermobility and enhance 
pressure transmission invoked by intra-abdominal straining. 
 However, competing theories arose initially as suggested by 
Zaccharin in the 1960s and DeLancey in the 1990s (Zaccharin, 1968 ; 
DeLancey, 1994). In these theories, the importance of the pubourethral 
ligaments and their function in maintaining the integrity of urinary 
control furthered the concept of the importance of the midurethral 
mechanism for preservation of urinary incontinence under stress 
circumstances. These findings further demonstrate the fact that 
hypermobility is a secondary finding noted in association with 
incontinence but not causative of the condition of effort-related urinary 
loss (stress incontinence).  
 Petros and Ulmsten, using these theories, proposed a unifying 
concept now known as the midurethra theory (previously the integral 
theory) (Petros and Ulmsten, 1993). They postulated that injury arising 
from surgery, parturition, ageing, or hormonal deprivation lead to 
weakening or damage of the pubourethral ligaments, impairing 
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midurethral function and anterior urethral wall support, thus resulting in 
urinary incontinence. They theorized that this damage was not only a 
ligamentous injury but also a representation of weakening of the 
pubococcygeal muscles at the level of the midurethra. It has been shown 
that weakness of soft tissue in this area and specifically connective tissue 
can contribute to urinary incontinence (Ulmsten et al, 1987). 
THE TENSION-FREE VAGINAL TAPE PROCEDURE  
 Transvaginal taping was developed using the concepts of the 
integral theory. The provisions of this operation include a minimally 
invasive approach, which would supplement the diminished midurethral 
mechanism and produce the ingrowth of new host tissues after 
implantation for purposes of further supplementing support introduced by 
the procedure. As initially described, the procedure was performed under 
local anesthesia to allow ambulatory delivery of the intervention. 
What does 'tension-free' mean? 
 Tension-free slings are used to treat stress urinary incontinence 
caused by urethral hypermobility and intrinsic sphincter deficiency. In 
this approach, a synthetic transvaginal  suburethral sling is placed through 
the retropubic space without using suspension sutures. The  sling is held 
in place by the friction between the mesh and the tissue canals created by 
the  metallic needle passers. Scar tissue later fixes the mesh, preventing 
migration. Because the sling  is not anchored to the pubic bone, 
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ligaments, or rectus fascia, it is considered "free of tension."  The result is 
a midcomplex urethral support that limits urethral descent, improves the  
stabilization mechanism generated by pubourethral ligaments and levator 
ani muscles, and  reinforces support of the backboard vaginal hammock. 
 Initially, several types of material were evaluated until the final 
material was chosen, a synthetic polypropylene monofilament mesh with 
pore size under 150 μm. Also, this material allowed optimal migration of 
host inflammatory components (leukocytes and macrophages) into the 
mesh for purposes of infectious surveillance and host wound healing 
(imbibition and inosculation). It was found that this material was optimal 
for inciting fibrous tissue ingrowth. This type of mesh is known as a type 
1 mesh and has previously been described in the general surgical 
literature as being favorable from the standpoints of its mechanical 
properties (stretch and elasticity) (Dietz et al, 2001, 2003). Efforts have 
been made to standardize the procedure by incorporating certain technical 
approaches and safety features for purposes of avoiding injury to 
surrounding structures.  
 To date, more than 400,000 of these procedures have been 
performed worldwide. 
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The Procedure  
 The device consists of two specially curved 5-mm-diameter 
insertion needles that are attached to a 40-cm segment of polypropylene 
tape that is 11 mm wide. The tape is covered with a clear plastic sheath, 
which protects the tape from contamination and allows easy passage 
through host tissues. A rigid catheter guide is placed in the bladder with 
an 18 French Foley catheter to help deflect the bladder away from the 
locale of needle path insertion. An ergonomic handle is attached to the 
insertion needles for actual placement of the needles during the 
procedure. This handle is reusable and sterilizable. 
 The midurethra sling procedure (transvaginal tape) is performed 
with the patient in the dorsal lithotomy position with a significant degree 
of flexion (70 degrees or more) of the thighs, the patient under parenteral 
sedation with  local anesthetics  placed in the region of insertion of the 
device (vaginal wall and  retropubic space). Approximately 5 mL of local 
anesthetic is injected into the vaginal area as well as into the planned 
suprapubic insertion skin sites. For placement of  retropubic local 
anesthesia, another 20 mL of local anesthetic agent is injected into the  
area along the posterior aspect of the pubic bone to the level of the 
urogenital diaphragm.  Additional vaginal infiltration includes 
approximately 10 mL injected on either side of  the urethra to the level of 
the urogenital diaphragm. 
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 After appropriate anesthesia, two small suprapubic stab incisions 
are created just above the level of the symphysis pubis, approximately 2 
cm lateral to the midline. A third midline vaginal incision approximately 
1.5 cm wide is created approximately 1.5 cm from the external meatus of 
the urethra, between that structure and the bladder neck.  
 After the vaginal incision is created, minimal dissection is 
performed using Metzenbaum scissors under the vaginal flaps on either 
side to elevate the vaginal epithelium from the underlying periurethral 
tissue to the level of the pubocervical fascia, which is not perforated. The 
tension-free vaginal tape (TVT) needle is then placed in the dissection 
tunnel immediately beneath the vaginal epithelium on one side of the 
urethra with the needle tip situated in close proximity to the lower rim of 
the pubic ramus. Using controlled pressure, the needle is elevated through 
the endopelvic fascia, into the space of Retzius, through the rectus 
muscles and through the previously created suprapubic skin incision. 
During this maneuver, the needle is kept in close contact with the 
intrapelvic surface of the pubic bone in order to avoid perforation of the 
lower urinary tract and also to avoid intraperitoneal entry. Tactile contact 
ensures direct apposition of metal to bone, as does slow graded pressure 
during needle advancement. 
 Simultaneous deflection of the lower urinary tract is accomplished 
during insertion using the catheter guide and catheter with pelvic viscera 
deflected away from the side of needle insertion. The same maneuver is 
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performed contralaterally so that each needle exits through the 
appropriate skin incision. Cystoscopy is performed to exclude needle 
penetration of the lower urinary tract. The use of a 70-degree lens is 
essential, as is complete distention of the bladder with irrigant to exclude 
subtle tangential injury. If perforation is noted, the needle is withdrawn 
and passed once more in the same area in an effort to avoid further 
perforation. Once cystoscopy has demonstrated no evidence of bladder 
injury, the tape is brought through the incisions and tension adjustment of 
the tape is performed. Tension adjustment is most commonly performed 
by inserting either a surgical instrument (clamp) or a metallic sound 
between the tape and urethra while the covering plastic sheath is removed 
from the field. The tape is set to tension such that with the bladder full to 
300 mL of saline and the patient now aroused and asked to cough, no 
incontinence occurs during the stress maneuver. Redundant tape is then 
excised at the level of the suprapubic skin incisions and all incisions are 
closed.  The procedure may also be performed under regional or general 
anesthesia according to the surgeon's preference. Outcome data support 
the incorporation of midurethral sling techniques with concomitant 
vaginal prolapse repairs. 
Results  
 In reviewing the extensive results reporting for the midurethral 
sling, several caveats must be entertained. Outcomes are reported in 
varying fashions using different tools, lengths of follow-up, and overall 
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definitions of success and failure. These factors should be kept in mind 
when attempting to cross-compare different groups and procedural 
nuances. 
 Initial results with the midurethral sling technique approximated 
80% (author-defined) success rates (Ulmsten et al, 1996). A subsequent 
prospective multicenter trial that included 130 women with genuine stress 
incontinence (GSI) who were observed for 1 year revealed success rates 
of 91% (Ulmsten et al, 1998). Seven percent were considered improved 
and only 2% deemed failures. Complication rates were low, including one 
bladder perforation and one wound infection. Voiding dysfunction was 
also relatively low, with one patient experiencing retention for 12 days, 
which resolved spontaneously, and three patients with less than 3 days of 
voiding dysfunction (regarding catheterization), which the authors 
defined as a short-term voiding problem. 
 On the basis of these findings, further studies were then embarked 
upon. Nilsson and Kuuva (2001) evaluated 161 consecutive TVT 
operations in cases of which 28% had failed prior incontinence surgery, 
11% had intrinsic sphincteric deficiency (ISD), and 37% had mixed 
incontinence. At 16 months mean follow-up, the overall objective cure 
rate was 87% with 7% significantly improved and another 5% considered 
failures.  
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 Bladder injury rate at the time of insertion was 3.7%, and 4.3% of 
women experienced short-term de novo voiding dysfunction. Urge 
symptoms arising after surgery occurred in 3% of women, yet 80% of the 
women who had preoperative urgency symptoms had relief of those 
symptoms at their 16-month visit. No serious complications were noted. 
 Long-term results mirror the short-term experience with this 
procedure. Success rates ranging from 81% to 90% have been reported at 
more than 3 years. Ulmsten (1999) reported an 86% success rate in 50 
women at 3 years. Olsson reported 90% success in 51 women at 3 years  
(Olsson and Kroon, 1999). Nilsson reported success rates of 84.7% at 5 
years ( Nilsson et al, 2001 ) and 81.3% at 7 years ( Nilsson et al, 2004 ) in 
a consistent cohort of 90 women. These long-term studies have attempted 
to evaluate risk factors for declining effectiveness. There does appear to 
be a tendency for higher failure rates to be associated with advancing age 
at the time of procedure and also with diminished urethral function 
(intrinsic sphincter deficiency). Notable, the long-term studies 
demonstrate an absence of signs of long-term tissue erosion or other 
complications related to material insertion. 
 The most stringent evaluation of this technique has occurred in four 
randomized controlled clinical trials that have compared it with the 
colposuspension procedure. The most meticulously designed trial was 
that of the UK/Ireland cooperative group, which compared TVT with 
open colposuspension. One hundred seventy-five women underwent TVT 
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and 169 underwent Burch suspension. Clinical follow-up was continued 
for 24 months. A variety of outcome measures including subjective and 
objective measures were utilized. Overall cure rates noted in the study 
were lower than other reported cure rates, with 63% of TVT patients and 
51% of colposuspension patients being cured  (Ward and Hilton, 2004 ).  
 Comparator Tabulation of Outcomes Obtained with the Tension-
Free Vaginal Tape and Burch Procedure in a Randomized Analysis  
  Tension-Free  
Vaginal Tape 
(%) 
Colposusp-
ension (%) 
Objective cure   
1-hour pad test 81 67 
Negative urodynamic studies + pad test 73 64 
Subjective cure 
  No stress incontinence 59 53 
  No incontinence 36 28 
Response to procedure 
  Satisfied 85 82 
  Recommend 84 82 
  
 From Ward K, Hilton P: A prospective multicenter randomized 
trial of tension-free vaginal tape and colposuspension for primary stress 
incontinence. Two-year follow-up. Am J Obstet Gynecol 2004;190:324-
331.  
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 Three other randomized trials have been performed: one that 
compared TVT with laparoscopic colposuspension using mesh (Valpas  
et al, 2004), another that used laparoscopic colposuspension with Gortex 
sutures as the comparator (Persson et al, 2002), and a third that used 
laparoscopic colposuspension with polyfilament polyester sutures as the 
comparator technique to TVT (Paraiso et al, 2004). Valpas and Persson 
reported results at 12 months, and Paraiso reported outcomes at 18 
months. The results of the laparoscopic trials revealed TVT cure rates in 
the range of 86% to 97%, with colposuspension rates ranging from 57% 
to 100%, depending on the reporting method.  
 There was no apparent difference between procedures in the 
Persson trial, but Paraiso and Valpas noted significant differences in 
success in the two study groups. These trials noted no other apparent 
differences between techniques other than that the TVT group recovered 
more rapidly and had a lower need for subsequent urogenital prolapse 
procedures than the colposuspension group.  
Complications  
 Despite its relative safety, the tension free vaginal tape procedures 
require the blind passage of needles through 2 small incisions in the 
abdomen just above the pubic bone. The retropubic space that the needle 
has to pass through to get to these abdominal incisions is also a very 
vascular space with venous plexuses and the potential for injury to large 
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blood vessels in the pelvis. Secondary to this and the areas that the needle 
has to pass to place the mesh tape, there is potential for complications 
such as injury to the bladder, intestines, or nerves in the pelvis and/or 
abdomen. All of these injuries have been reported in the literature. 
Secondary to this, physicians in Europe began  investigating to  find a 
safer approach to place the mesh tape sling. 
Risks of Retropubic Needle Passage 
   -Bladder injury,Bowel injury,Major vascular injury,Nerve injury 
      
Passage of Retropubic Needles for TVT, etc. 
 The needle on the left shows a safe passage, the needle on the right 
shows potential injury to abdominal wall vessels or pelvic vessels or 
nerve. Despite its relative safety, the tension free vaginal tape procedures 
require the blind passage of needles through 2 small incisions in the 
BLADDER 
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abdomen just above the pubic bone. The retropubic space that the needle 
has to pass through to get to these abdominal incisions is also a very 
vascular space with venous plexuses and the potential for injury to large 
blood vessels in the pelvis. Secondary to this and the areas that the needle 
has to pass to place the mesh tape, there is potential for complications 
such as injury to the bladder, intestines, or nerves in the pelvis and/or 
abdomen. 
TRANSOBTURATOR SLINGS 
 Subsequent to the development of the TVT, it was recognized that 
the transobturator (TOT) tape was a viable method for correction of SUI. 
Since Ulmsten's initial article in 1996, there has been extensive 
acceptance of the various midurethral sling technologies.  
 In Europe, as of 2005, approximately 83.9% of all procedures are 
midurethral-type synthetic slings, of which 26.9% are TOT ( de Tayrac 
and Medelenat, 2004 ). Since the initial description of the TOT approach, 
numerous other similar TOT approaches have been noted. 
 The goal of the minimally invasive surgical procedure should be to 
provide acceptable long-term efficacy comparable to that of more 
standard methods as well as a relatively low incidence of long-term 
complications, Delorme (2001) initially described the placement of 
synthetic polypropylene mesh using the TOT approach. The technique 
was described as being relatively facile and associated with fewer 
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complications than retropubic approaches. It was also thought that the 
procedure did not require cystoscopy. 
Advantages of Transobturator Approach 
-Safer, faster, more efficient -Decreased risk of: -Bowel Injury -
Bladder Injury -Major Bleeding -No Retropubic Needle Passage -No 
Abdominal Incisions  - More Anatomic Position of Tape 
 
 The double arrows show the final position of the transobturator 
sling placement. The blue circles in the groin are where the small stab 
incisions are made to place the polypropylene mesh tape sling 
                       
                       
 
 
Clitoris 
Urethral 
Meatus 
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Transobturator Anatomy 
 
OBTURATOR ANATOMY                                                                                               
 The obturator foramen is covered by a thick membrane called the 
obturator membrane. The external and internal obturator muscles cover 
this membrane. It is a very safe space anatomically, ie there are no major 
vascular or nerve structures near the ischiopubic ramus. This is the area 
that the needle is passed for the sling placement. As can be visualized by 
the drawing, the obturator canal is very lateral and superior to the 
ischiopubic ramus, this is the area that the obturator nerve and vessels 
transverse the needle to place the TOT sling is passed through the groin 
incision, the obturator membrane and around the descending ischiopubic 
ramus (the area marked in green in the above diagram). A small incision 
is made vaginally as well and the needle is guided throughout its course 
with a finger placed in the vaginal incision, thus protecting the urethra 
and making it safer than just a “blind” needle passage. The mesh tape is 
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then attached to  the needle and brought  back through the incision The 
obturator vessels and nerve coming  through the canal are far away from 
the surgical field, thus making injury very  unlikely. 
 The TOT needle used to place the sling has minimal blind 
passage making it very safe, additionally neither the needle nor the 
sling has to be    passed through the abdominal wall like traditional 
slings 
TOT Needle Passage 
_                                   
 demonstrates the positioning of the needle passage in the Monarc 
transobturator sling, made by  American Medical Systems. This is  just 
one of the types of TOT slings currently on the market. 
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 Demonstrates the passage of the needle viewed from the inside of 
the pelvis. Again a very safe  area to pass the needle through to place the 
sling. This area is below the fascia of the bladder and  therefore the 
retropubic space is never entered and the bladder remains very protected 
with this  approach.' 
TOT Mimics Normal Anatomy                                          
 The transobturator sling forms a subfascial hammock of support 
under the urethra. This mimics the normal position of the pubourethral 
ligament. This is the ligament that typically provides the backboard of 
support to help prevent urinary leakage with stress events such as 
coughing, laughing, sneezing, exercising, etc. When this ligament is 
damaged or stretched out secondary to childbirth, aging, chronic 
straining, etc, stress urinary leakage may ensue. The position of the 
transobturator sling reproduces the natural position of this ligament and in 
a sense replaces the damaged ligament with a permanent mesh tape that 
Needle  
entry & path 
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provides the support needed to prevent leakage  the angle of the TOT 
sling is  much less acute than the traditional pubovaginal sling procedures 
such as the TVT,  therefore not only is this more anatomic and natural, it 
also makes sense that there is less  problems with urinary dysfunction 
such as urinary obstruction.    
 MRI that demonstrates the position of the TOT sling is almost 
identical to the natural position of the pubourethral ligament. 
    
___________
__________ 
 The TOT sling (red) is shown in this MRI to mimic the natural 
position of the pubourethral  ligament (green) which is the ligament 
known to be responsible for maintaining continence. 
Operative Technique  
 Operative technique varies with insertion method. Various 
procedures using similar insertion methods represent relatively similar 
technique.   
 Not only does implantation technique affect overall success of the 
sling, but also the type of mesh or tape implanted has a substantive effect 
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upon overall results. Mesh properties have been shown to have a 
significant effect upon local inflammatory response and ingrowth of local 
fibrous tissues (collagen, neovascularity) and subsequent integration of 
these tapes into host tissues. These differences in properties are felt to 
affect the risk of erosion and subsequent infection and other vaginal and 
local complications. There are intrinsic differences between the various 
meshes that have been used for the TOT approach. The ObTape and 
UraTape meshes are polypropylene material but are small-pore, knitted 
and thermally bonded with an approximately 15-mm silicone component 
that is immediately suburethral in location after implantation. A second-
generation obturator tape developed by the Mentor Corporation is known 
as the Aris TOT; it has a larger 200-μm pore size that allows improved 
tissue ingrowth with less encapsulation. The ObTryx, TVT-O, Monarc, I 
STOP, and Urotex-TO are large-pore open knit polypropylene meshes. A 
unique obturator mesh is the BioArc, which, like the suprapubic variety, 
has a biologic graft material that is sutured on either end to the 
polypropylene tape. The biologic material actually occupies a suburethral 
position (deLeval, 2003 ; Delorme et al, 2003). 
 
 
 23 
 -- Devices and Descriptions  
Company Brand 
Name 
Mesh Material Pore Size (m) 
Mentor ObTape Prolene, 15-mm silicone 50 
  UraTape Prolene, 15-mm silicone 50 
  Aris Polypropylene 200 
AMS Monarc Knitted polypropylene Large, open 
knit 
  BioArc Polypropylene with biologic 
suburethral component 
Large, open 
knit 
GyneCare TVT-
Obturator 
Polypropylene Large, open 
knit 
Bard Uretex-TO Polypropylene Large pore 
Boston 
Scientific 
ObTryx Polypropylene with 
detangled suburethral 
segment 
Large pore, 
>100 
      >75, low 
weight/area 
CL Medical, 
France 
I STOP Monofilament prolene weave 
 
Transobturator Outside In   
 The patient is placed in the dorsal lithotomy position with legs in 
hyperflexion (120 degrees). A small vertical vaginal incision is created as 
with the TVT over the midurethra, and dissection is carried out laterally 
to the ischiopubic ramus. A puncture incision is made in the obturator 
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foramen at the level of the clitoris in the leg using the tunneler; the 
obturator membrane is perforated, at which point resistance is noted by 
the operative surgeon. Using the nondominant index finger and 
identifying the landmarks of ramus and the obturator internus muscle, the 
tunneler is turned in a medial orientation and advanced on the tip of the 
index finger and brought out through the vaginal incision.  
 Inspection is carried out at this point to exclude inadvertent 
penetration of the vaginal fornix or associated urinary structures. The 
synthetic material is then attached to the tunneler and brought out through 
the inner thigh stab wound. The procedure is then repeated on the 
contralateral side. Tension is set on the tape by passing a clamp between 
the tape and urethra such that a surgical clamp can be passed easily 
between these two structures. Excess material is then cut at the skin 
puncture site and the incisions are closed according to the surgeon's 
preference. This approach is used by the following devices: ObTape, 
UraTape, Aris TOT, Monarc, BioArc TO, Uretex-TO, ObTryx, I STOP. 
                                
 25 
Surgical Synopsis-TOT Sling 
        
  
 
 
 
Step 1. Small incision is made          Step2. Vaginal    
under the urethra               epithelium is dissected free 
___ _                            
 
 
 
 
Step 3 Area of groin incision located 1 cm  Step 4: Figner placed in  
inferior to adductor longus tendinous   vaginal incision to  
insertion (level of clitoris)   guide needle. Needle  
       placed in groin incision and 
       passed.  
 Then the needle is passed through the groin incision, through the 
obturator membrane and muscles and brought into the vaginal incision. 
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__ ___                                  _  
 
 
 
Step 5. The needle is brought through the vaginal incision and the tape is 
attached to the needle with the connector. 
__ _ _ _  
 
 
 
 
 
Step 6. Connected tape is   then brought back through the groin incision                             
__                                                                      ___  
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Step 7. Needle and tape is passed on the opposite side. Tape is then 
adjusted with an intra-operative cough test and adjusted until no leakage 
occurs. Excess mesh is cut off at the groin incisions and these are closed 
with steri-strips and vaginal incision is closed with absorbable suture  
TOT inside out 
 The patient is placed in the gynaecological position with thighs in 
hyperflexion. After the usual preparation of the patient a urethral catheter 
is inserted into the bladder, which is emptied. Then the local or regional  
anaesthesia is performed. The anterior vaginal wall is incised at a length 
of 1 cm and at a distance of 1 cm proximally to the urethral meatus. This 
step is followed by introducing fine dissection scissors through the initial 
dissection pathtowards the upper part of the ischio-pubic ramus on a 
horizontal plane with a 45degree angle to the urethral sagittal plane. Once 
the upper part of the ischio-pubic  ramus is reached, the obturator 
membrane is perforated with the tip of the scissors. An introducer, with 
the open side of its gutter facing the surgeon, is pushed along the  
preformed dissection canal  until it reaches and perforates the obturator 
membrane. The distal end of the tube mounted onto the spiral segment of 
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the needle  is gently slipped  along the gutter of the  introducer in order to 
pass through the obturator foramen . Then the introducer is removed. 
After the tube has appeared at the previously  determined skin exit point , 
the tube is pulled off from the supporting needle, which is removed. The 
same technique is applied at the other side. Next the ends of the  tape are 
cut, the tape is aligned under the middle of the urethra, creating space and  
avoiding any tension of the tape by introducing curved scissors under the 
tap thus creating a small loop of 5 mm. The plastic sheaths are then  
removed simultaneously. The tape ends are cut in the subcutaneous layer 
and the incisions are closed. Postoperative indwelling catheterisation is 
done in regional anesthesia patients. Catheter removed on the next day.   
       
Median sagittal incision of the vaginal      Gynecare TVT-O special  
                  device. 
wall. Introduction of fine dissection  
scissors towards the upper part of  
the ischio-pubic ramus to perforate  
the obturator membrane. 
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 The introducer is pushed along the preformed dissection canal until 
it perforates the obturator membrane. The tube mounted onto the spiral 
segment of the needle is slipped along the gutter of the introducer so as to 
pass through the obturator foramen 
 
 The tube appears at the previously determined skin exit point  
a. The skin exit points are identified by tracing a horizontal line at the 
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level of the urethral meatus and a second line parallel and 2 cm above the 
first line. The exit points are located at the second line 2 cm outside of the 
genitofemoral folds. 
 
 Schematic drawing of the position of the TVT-O, important 
neighbouring  structures and insertion points of the adductor muscles of 
the thigh: a, musculus pectineus; b, musculus adductor longus; c, 
musculus gracilis; d, musculus adductor brevis; e, musculus adductor 
magnus; f, tape; g, canalis obturatorius with the obturator nerve, artery 
and vein; h, vesicarinaria. 
Results  
 Since the initial description by Delorme in 2001 , continence rates 
have been reproducibly satisfactory although follow-up has, in general, 
been short Reported continence rates range from 80.5% to 96% on the 
basis of a variety of subjective (questionnaire and quality of life single-
item assessment) and objective (cough stress test, uroflowmetry, physical 
examination) measures.  
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Outcomes with Transobturator Techniques  
Study N Follow-
up 
Cured/Improv
ed/Failed 
Assessment 
of Outcome 
Patients' 
Age 
Pure 
SUI 
Mixed 
UI 
ISD Previous 
Anti-
Incontin
ence 
Surgery 
Prehysterec
tomy 
Concomita
nt Prolapse 
Repair 
Delorme 
et al, 
2003  
150 
(32w/
1 
year 
f/u) 
17 mo 
(13-29) 
90.6%; 9.4%; 
0 
Cough 
stress test; 
uroflow 
64 (50-
81) 
14 
(44%) 
18 
(56%) 
5 
(15.6%) 
5 
(15.6%) 
5 (15.6%) 0 
Costa et 
al, 2004  
183 7 mo 
(1-21) 
80.5%; 7.5%; 
12% 
Cough 
stress 
test/questio
nnaire 
56yr 
(29-87) 
53% 27.30
% 
10 
(MUCP 
<20 cm 
H2O); 
5.4% 
14.20% 25.70% 26 (14.2%) 
de 
Tayrac 
et al, 
2004  
30 12 mo 90%; 3.3%; 
6.7% 92% 
objective cure; 
97% 
subjective; 
Cough 
stress 
test/questio
nnaire 
54.7 27 3 4 4 2 (4 
previous 
prolapse 
sx) 
None 
Cindolo 
et al, 
2004  
80 4 mo 
(1-8) 
96% overall 
satisfaction 
Questionna
ire/quality 
of life 
instrument 
56 (39-
79) 
62 
with 
+ Q-
tip 
test 
(78%) 
22 
(28%) 
NA 16 
(20%) 
NA None 
Mellier 
et al, 
2004  
94 12.8 
mo (2-
20) 
95% cured; 
4%; 1% 
Telephone 
based 
Questionna
ire 
58.1  
(± 9.3) 
94 
(100
%) 
define
d on 
three-
grade 
scale 
12 
(13%) 
preop 
urgen
cy 
26 
(28%) 
MUCP < 
30 
28 
(30%) 
17 (18%) None 
Queimad
elos et 
al, 2004  
47 18 mo 45/47 (96%) Questionna
ire 
55 (40-
69) 
47 0 3 NA NA 0 
Krauth 
et al, 
2005  
604 
(140
w/1 
year 
f/u) 
1-3 mo 
in 572; 
1yr in 
140 
85.5% 
satisfied at 1yr 
Subjective 
questioning 
57 47.30
% 
52.70
% 
Not 
reported 
Not 
reported 
Not 
reported 
8% 
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Efficacy  
 Efficacy analyses have included heterogeneous groups of patients 
including those in whom prior procedures failed, those who had 
concomitant prolapse, and those with mixed incontinence. Delorme 
(2001) noted that 15.6% of his patients had ISD, and Mellier and 
colleagues (2004) diagnosed 28% of their patients with ISD. Despite 
these diverse populations of patients, relatively similar results were 
obtained. However, no preoperative predictors of outcomes using either 
clinical or urodynamic parameters were established to determine overall 
results of these procedures. Therefore, the effect of mixed incontinence, 
ISD, and concomitant prolapse on surgical outcomes for this intervention 
are unknown. Prospective studies are needed to answer these questions. 
 Two nonrandomized studies have compared TOT with TVT 
procedures and have found no significant difference in postoperative 
voiding dysfunction, complications, or overall continence. There was a 
tendency toward more bladder injuries (10% versus 0%) and hemorrhage 
(10% versus 2%) with the suprapubic as compared with the TOT 
approach, but this did not reach statistical significance (de Tayrac et al, 
2004 ; Mellier et al, 2004 ). 
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Complications of the Transobturator Approach  
 Despite the minimally invasive nature of these procedures, peri- 
and postoperative complications have been reported with a variety of 
techniques. 
 Bladder perforation appears to be the most common complication 
associated with any midurethral sling, with a 2% to 11% risk with the 
suprapubic approach. Although initial reports described the risk with the 
TOT approach as being negligible, the risk of bladder injury is now 
identified as associated with this sling insertion technique.   
 -- Complications Associated With TOT Techniques  
Study N Adverse Events 
Delorme et al, 2003  32 None reported 
de Leval, 2003  107 One superficial vein thrombosis 
with abscess; ?(27/107) 15.9% 
transient thigh pain 
Domingo et al, 2005  65 Nine vaginal mesh erosion 
Costa et al, 2004  183 Three vaginal erosion; two urethral 
erosion; one bladder perforation; 
one vaginal perforation; two 
urethral perforation 
de Tayrac et al, 2004  30 Six uncomplicated UTI; one 
obturator hematoma 
Cindolo et al, 2004  80 One vaginal erosion with inguinal 
abscess 
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Study N Adverse Events 
Mellier et al, 2004  94 2% intraop hemmorhage (300 mL); 
one urethral perforation 
Queimadelos et al, 
2004  
47 None reported 
Krauth et al, 2005  604 (140 
with 1-year 
Follow-up 
0.3% vaginal erosion; 2.5%UTI; 
0.5% bladder perforation; 0.33% 
vaginal perforation; 2.3% perineal 
pain 
 
 Minaglia and colleagues (2004) reported three cases of 
intraoperative bladder injury while performing the TOT insertion method. 
They identified all injuries intraoperatively because of their utilization of 
cystoscopy as an adjunct to all insertion procedures. All injuries were 
managed with catheter placement for 1 week postoperatively, and these 
authors noted no complications after sling removal and reinsertion at that 
same setting. 
 To date, no case of bladder injury when performing the TOT by the 
inside-out approach has been reported using the TVT-O (Hermieu et al, 
2003 ; Whiteside and Walters, 2004). 
 Domingo and coauthors (2005) reported a relatively high incidence 
of vaginal erosion in their series using either the ObTape or UraTape. 
They attributed their erosion rate to the characteristics of the particular 
mesh that they utilized, with the reduced pore size and other mechanical 
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properties of that particular material. They noted a slightly increased risk 
of erosion with the ObTape (15-mm silicone-coated portion), 19% versus 
12% compared with the UraTape, and they felt that this was most likely 
due to reduction in pore size and higher degree of encapsulation. They 
also concluded that synthetic mesh with larger pore sizes facilitates 
vascular and tissue ingrowth, optimizing mesh incorporation. Tape 
erosion was usually managed by removal by the transvaginal approach 
alone or combined with the transobturator approach. They noted 
continence rates of 78% (despite tape removal in their series) ( Domingo 
et al, 2005). 
 Postoperative voiding dysfunction has been noted to occur in 0% to 
20.6% of patients following TVT ( Pesschers et al, 2000 ). The incidence 
following TOT procedures varies between 2.1% and 6.7%. There appears 
to be no significant difference in postoperative voiding dysfunction 
between the TVT and TOT in nonrandomized studies (Mansoor et al, 
2003 ; de Tayrac et al, 2004 ). Urinary retention also appears to be not 
significantly different. The rate of obstructive symptoms after the TOT 
midurethral sling varies between 1.5% and 15.6% of patients. This 
phenomenon is usually transient and managed with short-term 
intermittent catheterization, although occasionally symptoms mandate 
tape release. Long-term retention after TVT is a rare complication (0.6% 
to 3.8%) and can be expected in the TOT population as well ( deTayrac et 
al, 2004 ). Removal of the tape, in most cases, improves the patient's 
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symptoms. There has been some anecdotal experience with downward 
displacement of the tape under local anesthesia to provide symptomatic 
relief in patients with persistent voiding dysfunction (Ozel et al, 2004).  
 Nonetheless, the overall risk of postoperative voiding dysfunction 
after the TOT is relatively low. Another bothersome complication, unique 
to the TOT approach, is that of postoperative leg pain. de Leval (2003) 
described 15.9% of patients with temporary groin pain that resolved after 
the second postoperative day. Similarly, Krauth and associates (2005) 
reported 14 cases (2.3%) of patients with postoperative perineal groin 
pain. They also noted it to be transient and responding to nonsteroidal 
anti-inflammatories in all but one case. They hypothesized that the 
etiology of the pain was either subclinical hematoma or a transient 
neuropathic phenomenon. They recommended that persistent leg pain that 
does not respond to conservative measures should prompt an 
investigation to exclude the possibility of erosion, which has been 
reported in several case reports ( Mahajan et al, 2006). 
 Infection-related complications have included thigh abscess 
requiring drainage (Goldman, 2005 ) and an infected obturator hematoma 
also requiring exploration and drainage ( Game et al, 2004 ). 
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DEFINITION  OF URINARY INCONTINENCE  
 The International Continence Society (ICS) defines the symptom 
of urinary incontinence as “the complaint of any involuntary loss of 
urine”  
 Stress urinary incontinence. The symptom is the complaint of 
involuntary leakage on exertion or on sneezing or coughing. The sign is 
the observation of involuntary urinary loss from the urethra synchronous 
with exertion, sneezing, or coughing.  
 Urodynamic stress incontinence is noted during urodynamic testing 
(filling cystometry) and is defined as the involuntary leakage of urine 
during increases in abdominal pressure in the absence of a detrusor 
contraction. 
 Urge urinary incontinence. The symptom is the complaint of an 
involuntary leakage accompanied by or immediately preceded by 
urgency. The sign is the observation of involuntary urinary loss from the 
urethra that is accompanied by or immediately preceded by urgency. 
Detrusor overactivity incontinence is incontinence related to an 
involuntary detrusor contraction during urodynamics. 
 Mixed urinary incontinence. The complaint of an involuntary 
leakage of urine associated with urgency and also with exertion, effort, 
sneezing, or coughing. 
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EPIDEMOLOGY OF URINARY INCONTINENCE 
Urinary Incontinence in Women  
 Urinary incontinence is more prevalent in women than in men, 
making gender itself a risk factor.  prevalence ranged from 5% to 72% 
among community-dwelling women Hunskaar and colleagues (2005) 
summarized available epidemiologic data and concluded that 
incontinence does show increasing prevalence during young adult life 
(20% to 30%), a broad peak around middle age (30% to 40%), and then a 
steady increase in elderly women (30% to 50%).  In young and middle-
aged women, stress incontinence predominates and in older women 
mixed incontinence is most common. Over all age groups, stress 
incontinence is most common (49%) followed by mixed incontinence 
(29%) and pure urge incontinence (21%).  
 Risk factors for the development of urinary incontinence are age, 
parity, route of delivery, and obesity have been the most rigorously 
studied risk factors.  Incontinence during pregnancy has a prevalence of 
31% to 60% but it resolves in most cases.  It has long been suspected that 
there is an association of urinary symptoms, including incontinence, with 
menopause.  
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Sphincteric Mechanism and Anatomic Support  
 Traditionally, the urethral sphincter is considered to be composed 
of two components: the internal sphincter, which represents a direct 
continuation of the detrusor smooth muscle, and the striated external 
sphincter. The principles underlying the function of a sphincter are (1) 
watertight apposition of the urethral lumen, (2) compression of the wall 
around the lumen, (3) structural support to keep the proximal urethra 
from moving during increases in pressure, (4) a means of compensating 
for abdominal pressure changes (pressure transmission), and (5) neural 
control. Thus, normal sphincteric function is the result of an integrated 
interaction among all these factors. 
Management of Incontinence Caused by Sphincteric Dysfunction 
(Stress Incontinence).  
Rehabilitative Techniques: Behavior Modification, Pelvic Floor 
Muscle Training, and Electrical Stimulation , conservative techniques 
including decreasing fluid intake, dietary and lifestyle changes, and 
programmed voiding by the clock have been used to treat SUI and seem 
to make common sense, especially in less severe and bothersome cases.  
After these techniques, PFMT is next in the line of conservative 
management for SUI.  The rationale for PFMT in the treatment of SUI is 
to improve strength or timing, or both, of the pelvic floor muscle 
contraction.  Several randomized studies have shown that PFMT is better 
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than no treatment for women with SUI  It appears that the most 
intensively supervised PFMT programs produce the best results, Until 
recently, pharmacologic treatment has been largely confined to α-
adrenergic agonists and estrogens.However, a review of randomized and 
quasi-randomized studies by the Agency for Health Care Policy and 
Research (1992) and the Cochrane database  suggests that there is only 
weak evidence to suggest that any α-adrenergic agent is better than 
placebo.  Agents that inhibit the uptake of serotonin and norepinephrine 
have also been used  to treat SUI. Estrogens have been used empirically 
to treat incontinence in women at least since the report of Salmon and 
colleagues  
Urethral Bulking Agents  
 Urethral bulking agents have been used for decades to treat SUI in 
women. Urethral bulking agents probably work by augmenting the 
submucosal layer of the urethra and increasing the compressive force 
inward toward the urethral lumen. They have no effect on urethral 
mobility. A variety of substances have been reported to be safe and 
effective including bovine glutaraldehyde cross-linked collagen , carbon-
coated zirconium beads polytetrafluoroethylene, polydimethylsiloxane 
elastomer, dimethyl sulfoxide in ethylene vinyl alcohol, and autologous 
tissues such as fat and cartilage. These agents are usually injected in a 
retrograde fashion using cystoscopic guidance or special delivery 
systems. In most cases, periurethral injections are simple office 
procedures, which may be accomplished with the patient under local 
anesthesia. 
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Surgery for Stress Incontinence in Females  
 Surgical treatment of sphincteric incontinence may be divided into 
sling procedures, suspension procedures (transvaginal and retropubic), 
and sphincter prostheses. The choice of procedure depends upon several 
factors, including (1) the underlying condition—degree of urethral 
mobility and leak point pressure, (2) available outcome data on various 
procedures, (3) surgeon preference and expertise, and (4) patient-related 
factors such as age, comorbid conditions, desire for a fast recovery, and 
avoidance of potential complications. 
 In 1997, the AUA Stress Urinary Incontinence Clinical Guideline 
Panel concluded that patients should be informed of the available surgical 
alternatives and the estimated risks and benefits of each procedure, 
including complications and how they would be treated.  
 As far as evaluating individual procedures, although much of the 
available data was inadequate, the panel concluded that retropubic 
suspensions (e.g., colposuspension) and slings were the most efficacious 
procedures for long-term success. These procedures had 84% and 83% 
cure/improvement rates at a minimum of 4 years of follow-up.  
 In the decade since the AUA Stress Urinary Incontinence Panel 
guidelines were published, midurethral tension-free synthetic slings such 
as the tension-free vaginal tape (TVT) have become the most popular 
procedures worldwide for the treatment of female SUI. Available short- 
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and intermediate-term prospective data suggest that these procedures give 
comparable results to traditional pubovaginal sling and colposuspension 
with cure rates in the 80% to 94% range; however, there is some concern 
about serious complications during the learning curve and the long-term 
consequences of urethral and vaginal erosions of the sling material. 
The artificial urinary sphincter (AUS) has been used to treat SUI in 
women. Because of the high success rates of sling surgery and retropubic 
suspensions, the AUS is rarely used in women. In cases of mixed 
incontinence with a predominant stress component,  successful surgical 
correction of stress incontinence has been shown to cure or improve urge 
incontinence in 50% to 93% of cases.  
                                       
 
 
 
 
 
 43 
MATERIALS AND METHODS 
 All female patients  with SUI who underwent TOT procedure  from 
September 2007 to  March 2009  were included .The study was 
prospective study, conducted in Department of  Urology, GRH and 
KMCH.  
Total number of patients included in this study were 60. 
Age distribution 
 30-35 years    -    12;  36-40 years     - 12;   41-45 years  -  15; 
 46-50 years   -    09;   51-60  years    -06;    >60 years     -  06.  
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 All patients were evaluated with history including bladder diary pre 
operative.  International Consulation on  continence Questionnaire and 
Urogenital Distress Inventory. physical examination including pelvic 
examination, urinalysis, urodynamic  studies  
                                                    Parity 
                               Parity                     No. of   Patients 
 
                                       1                                   3 
                                  2                               30 
                                  3                               18 
                                       4                                   6 
                                       > 4                                3 
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Mode of delivery    
                                                              
                                    Vaginal 54       LSCS 6 
                                              
 
Menstrual status 
         Premenopausal  25            Post menopausal  35 
 Comorbid illness 
Obesity                         20              Bronchial asthma        7 
Diabetes                       12              Hypertension                06  
International Consulation on  continence Questionnorie 
1. How often do you leak urine?       
0 Never                                  1 About once a week or less often 
 2 Two or three times a week        3 About once a day 
 4 Several times a day                   5 All the time 
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2..How much urine do you  usually leak (whether you wear protection or 
not)? 
0 None   1 A small amount    2 A moderate amount       3 A large amount 
3. Overall, how much does this  interfere with your everyday life? 
ring a number between 0 (not at all) and 10 (a greatdeal) 
0 1 2 3                                                 4 5 6 7                               8 9 10 
not at all                                                                                      a great deal 
  
4. When does urine leak? 
Never – urine does not leak              Leaks before you can get to the toilet 
Leaks when you cough or sneeze     Leaks when you are asleep 
Leaks when you are physically active/exercising    
Leaks when you have finished urinating and are dressed         
Leaks for no obvious reason 
Leaks all the time 
Urogenital Distress Inventory 
How much are you bothered by:                    (“X” one for each question) 
   Not at all            Slightly     Moderately     Greatly 
1. Frequent urination?           ฀                    ฀                  ฀                     ฀ 
 
2. Urine leakage related to the feeling 
of urgency?                           ฀                    ฀                   ฀                    ฀ 
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3. Urine leakage related to physical 
activity, coughing, or sneezing? ฀               ฀                   ฀                   ฀ 
4. Small amounts of urine leakage 
drops?                                           ฀                   ฀                ฀                  ฀ 
  
5. Difficulty emptying your bladder?       ฀           ฀           ฀                 ฀ 
 
6. Pain or discomfort in the lower 
abdominal or genital area?           ฀                     ฀                 ฀               ฀ 
Bladder diary 
Time Amount and 
type of fluid 
in           
Time   Amount of 
Urine 
released    
Comments to   
leakage,urge,pain,etc   
 
Clinical features 
Patient with pure stress leak          70% 
           Patients with SUI & UI                 30% 
Associated conditions 
Cystocele              -   4                                   Rectocele              -   1 
Fibroid uterus      -    2                                   Vault prolapse      -   3 
Prolopse uterus    -    2 
Investigations 
USG  ABD KUB with post void residual urine. 
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Urine c/s 
 UDE  in 18 cases with more of irritative voiding symptoms  
 The history of SUI and bother some symptoms with the 
demonstration of SUI during physical examination or  urodynamic   
studies constituted an indication for the TOT procedure. 
 Patients with  pure urge incontinence were excluded 
 
 All patients were required to have a minimal follow-up of 12 
months.  
 We defined the cure of SUI as the disappearance of subjective and 
objective SUI using Urogenital Distress Inventory   and    negative cough 
test on physical examination at 1week,6 months and 1 year. 
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PROCEDURE 
 
 
INSIDE OUT APPROACH –TOT 
 
 
 
 
        Introducer                                               Under SA the patient is placed in  
        dorsal   lithotomy position.                                     
                                                               Intra operative cystoscopy done    
 Stab incisions  are  created  approximately  2 cm  superior  to  the  
horizontal line  level  with  the  urethra   and  2 cm     lateral to the labial 
folds   2cm mid urethral incision vertically begins 1 cm from external 
urethral  meatus. 
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 The intoducer passes at 45 degree angle and perforate the obturator 
membrane and exits through the stab incision. 
 The procedure repeated on the opposite side 
                        
          All plastic covering sheaths are then removed 
Excess material excised. 
Maintaining no tension upon the sling. 
Vaginal incision and stab incision closed. 
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OUTSIDE IN APPROACH-TOT 
                             
 The patient is placed in the dorsal lithotomy  position. 
 A small vertical vaginal incision is created  over the mid urethra 
                                             
A puncture incision is made at the       The needle is turned in a medial  
level of  the clitoris in the obturator  orientation and advanced on the                   
foramen                          tip of the index  finger & brought  
The needle passed via stab incision      out through the vaginal incision. 
                                                    Intraoperative cystoscopy  done 
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 The synthetic material is then attached to the needle and brought 
out through the stab wound.  
 The procedure is then repeated on the contralateral side. 
     
 Maintain no tension on the tape by passing a curved scissors 
between the tape and urethra. Excess material is then cut at the skin 
puncture site and the incisions are closed Foley Catheterisation done, 
removed on the next day.  
Associated repair done simultaneously  for four cystocele and one 
rectocele. Trial vaginal  hysterectomy done for 2 fibroid uterus patients, 
both are about 14-16 week  size, mobile  uterus. 2 vaginal hysterectomy 
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for prolopse uterus patients.3 vault prolopse patients  underwent Bilateral 
sacro spinous colpo suspension. 
Assessment of outcome 
 Cough stress test 
 Subjective questionnaire 
 We defined the cure of SUI as the disappearance of subjective and 
objective SUI using   in Urogenital Distress Inventory and International 
Consultation on continence Questionnaire score and negative cough test 
on physical examination after 1week, 1and 12 months. 
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RESULTS AND OUTCOME 
 50 patients under spinal anaesthesia 10 patients under IV Sedation 
 The mean operative time was 12 min (6–30) in cases of isolated 
SUI treatment.  
 The catheterisation time was 0.9 day (0–2). 
  No significant blood loss occurred in any cases 
 
            
Outcome  1 
month 
Outcome   
1 year 
Cured 93% 80% 
Improved 4% 12% 
Failed      
 
3% 8% 
 
 At one month, 93% of patients (56/60) were cured and 3.5% (2/60) 
of persistent voiding dysfunction with de novo urgency or urge 
incontinence who needed  simple follow up.  
Perineal pain was observed in 1 patient (2.5%) – Lasted for 3 months 
Post operative leg pain in 4 patients (7%) -  Lasted for 2 to 6 months 
No vaginal erosion was observed at this point. 
No perioperative complications noted 
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 2 urinary retention  after removal of the catheter on post-operative 
day 1, one for 15 days and the other one not recovered ,patient advised  
splitting of the tape under mid urethra..Patient was not willing , hence self 
catheterisation  was taught. 
 Two lower urinary tract infections were observed in the immediate 
post-operative period. 
At one year, 48 of 60 patients (80%) were clinically cured from 
their stress incontinence and an  additional 12% were also improved. 
All patients answered adequately to questionnaire 
Complications 
 Bladder injury                                       - nil 
Vaginal erosion                                     - nil 
Voiding dysfunction  
  Irritative symptoms                    - two 
           Obstructive  symptoms              - two 
Post operative perineal  pain              -  one 
Post operative leg pain in                    -  four   
Infection 
           Thigh abcess                              -nil  
  Infected obturator hematoma    -nil 
  lower urinary tract infections   - two 
 Vascular,Nerve injury                        -nil 
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DISCUSSION 
 The main goal of the surgical treatment of Stress Urinary 
Incontinence  is to restore a perfect continence with  minimal morbidity. 
Although it is effective and easy to perform, the retropubic placement  of 
suburethral tension-free vaginal tape  has been associated with a number 
of  peri and post-operative complications including bowel, vascular and 
bladder injuries ,  and but also dysuria, urinary retention and de novo 
symptoms. Most complications  appear to be related to the blind upward 
vaginal passage of the trocars in the retropubic  space.  
 The perineal approach reproduces the natural support of the urethra 
as clearly explained by the Hammock hypothesis of de Lancey  while 
preserving an intact retropubic space. Delorme et al. described the trans-
obturator approach as an excellent alternative to the retropubic approach 
that reduces complications. 
 In our series, no lower urinary tract  injuries were seen. A  Vertical 
incision is made in the anterior vaginal wall at the level of  the mid 
urethra, hydro dissection facilitate easy dissection.The anterior vaginal 
wall is  reflected off  the underlying peri urethral tissue.  A finger placed 
in the dissected vaginal  space guards the urethra from the needle.   
 Regarding post-operative complications, the 2   urinary retention 
occurred  most probably due to excessive tension on the tape. In case of   
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obstructive voiding difficulties, it is firmly recommended to release the 
tape within the first  week. The most  important issue is that the tape must 
be adjusted without any tension nor  any contact with  the urethra.  
 To avoid vaginal erosion, a deep incision of the Halban fascia on 
the midline of the vagina must be done associated with a cautious closure 
of the vaginal mucosa. 
 The non-woven polypropylene mono filament with macropores 
allow good fibroblasts colonisation of the tape which is essential in 
preventing erosion and local infection.  
 TOT is not associated in our experience with the risk of severe 
injuries confirming the interest of the perineal approach and the 
procedure is nowadays usually performed in  day  care setting . We do 
not have a clear explanation for the persistent perineal pain in some 
patients, but it was not due to obturator nerve trauma, as the distance 
between the zone for needle insertion and the obturator canal is 
approximately 3.5 to 4 cm with no neuro-vascular elements in contact 
with the tape and it settled with analgesics. 
 Pelvic Floor Musle Training is usually performed in our 
department as the initial approach. In case of  insufficient response,  or in 
patients with very significant leak surgery is recommended. Despite its 
limitations, pre-operative physiotherapy could perhaps improve long term 
efficacy of the surgical  procedure. 
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 We have done associated cystocele and rectocele repair 
simultaneously.Trial vaginal hysterectomy done for 2 fibroid uterus 
patients,both are about 14-16 week size, mobile uterus with minimal 
descent 2 vaginal hysterectomy for prolopse uterus patients.3 vault 
prolopse patients underwent Bilateral sacro spinous colpo suspension. 
 At one month, results concerning continence are excellent and 
comparable to other results obtained with the TVT  procedure in world 
wide publications. 
 At one year, the cure rate is 80% and 12% of the patients are 
significantly improved Longer follow up will confirm or refute this trend. 
De novo symptoms such as urgency or urge incontinence were observed 
in 2 patients only This confirms data published in previous studies with 
TOT .These results are much lower compared with those on TVT® . 
Noteworthy pre-operative urgency and urge incontinence disappeared in 
97% of cases without anticholinergic drugs. The trans-obturator route 
considerably limits de novo symptoms, probably due to the horizontally 
placed tape below the urethra with no tension between the two 
ischiopubic rami. 
 Nevertheless, questionnaire shows excellent results regarding the 
different dimensions scores. This is very important when assessing 
functional results. 
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Complications associated with TOT-other studies 
Study                                            N    Adverse  Events 
 Delorme et al, 2003         32      None reported 
 Domingo et al, 2005        65      Nine vaginal mesh erosion 
 de Tayrac et al, 2004       30      6 uncomplicated  UTI; 1 obturator 
     hematoma 
 Cindolo et al, 2004           80     One vaginal erosion with inguinal 
              abscess 
 Mellier et al, 2004             94   2% intra op haemorhage (300 ml);  
                                                             one urethral perforation 
 Queimadelos et al, 2004  47    None reported 
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Comparision with other studies 
Study N Age Follow 
up 
Cured 
 
Improved 
 
Failed 
 
Assessment 
of out come 
 
Delorme  
et 
al,2003 
 
150 50-81 17  
months 
 
90.6% 
 
9.40% 
 
0 cough 
stress test. 
uroflow 
 
de 
Tayrac 
et al, 
2004 
 
30 54.7 12  
months 
 
80.5% 
 
7.50% 
 
12% cough 
stress test. 
questionaire 
 
mellier 
et al, 
2004 
 
94 58.1+/- 
9.3 
 
12.8 
months 
 
95% 
 
4% 
 
1% questionaire 
 
Our 
study 
 
60 30-63 1-12 
months 
80% 12% 08% cough 
stress test. 
questionaire 
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CONCLUSION 
 Trans obturator tape is a simple, effective and safe procedure for 
the treatment of  female stress urinary incontinence confirmed after 
1 year of follow-up. 
 It offers increased safety.  
 The post-operative morbidities associated with this technique are 
minimal and manageable. 
  Evaluation of the results after a longer follow-up period is needed. 
 The learning curve is simple and easy.                                                 
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 MASTER CHART  
 
Sl 
No 
Name Age Sex IP No Presentation Diagnosis Urine  
c/s 
USG UDE Procedure Outcome 
1 Rani 30 F 5372 Stress leak SUI NG Normal  TOT-Outsidein Cured 
2 Poongothai 36 F 5674 Stress leak+UI MI NG Normal Leak demonstrared TOT-Outsidein Cured 
3 Padma 41 F 6012 Stress leak SUI NG Normal  TOT Outsidein Cured 
4 Jeya lakshmi 46 F 6298 Stress leak SUI Proteus Normal  TOT Outsidein Failed 
5 Anjalai 32 F 6987 Stress leak+UI MI E.coli Normal Leak demonstrared TOT Outsidein Improved 
6 Kannagi 38 F 7098 Stress leak SUI NG Normal  TOT Outsidein Cured 
7 Indumathi 44 F 8765 Stress leak SUI NG Normal  TOT Outsidein Cured 
8 Fathima 50 F 9125 Stress leak SUI NG Normal  TOT Outsidein Cured 
9 Valarmathi 34 F 9543 Stress leak SUI NG Normal  TOT inside out Cured 
10 Eswari 37 F 10234 Stress leak SUI NG Normal  TOT inside out Cured 
11 Kannika 42 F 10765 Stress leak+UI MI NG Normal Leak demonstrared TOT Outsidein Cured 
12 Jasmine 51 F 11256 Stress leak SUI NG Normal  TOT inside out Cured 
13 Thayammal 49 F 11754 Stress leak SUI NG Normal  TOT Outsidein Cured 
14 Chitra 35 F 12478 Stress leak SUI NG Normal  TOT inside out Cured 
15 Navamani 37 F 13012 Stress leak+UI MI NG Normal Leak demonstrared TOT-Outsidein Cured 
16 Kalyani 43 F 13653 Stress leak SUI NG Fibroid Uterus  TOT inside out Improved 
17 Vijayalakshmi 53 F 13978 Stress leak SUI NG Normal  TOT-Outsidein Improved 
18 Shanthi 33 F 14238 Stress leak+UI MI NG Normal Leak demonstrared TOT-Outsidein Cured 
19 Lalitha 40 F 14295 Stress leak SUI NG Normal  TOT inside out Cured 
20 Panjali 44 F 14839 Stress leak SUI NG Normal  TOT-Outsidein Cured 
21 Valli 47 F 15378 Stress leak SUI NG Normal  TOT inside out Cured 
22 Ramya 32 F 15289 Stress leak+UI MI NG Normal Leak demonstrared TOT-Outsidein Cured 
23 Andal 39 F 15673 Stress leak SUI E.coli Normal  TOT inside out Cured 
24 Muniyammal 45 F 15987 Stress leak SUI NG Normal  TOT-Outsidein failed 
25 Porkodi 31 F 16342 Stress leak SUI NG Normal  TOT inside out Cured 
26 Angammal 36 F 16543 Stress leak+UI MI NG Normal Leak demonstrared TOT-Outsidein Cured 
27 Pachaiammal 55 F 16598 Stress leak SUI NG Normal  TOT inside out Cured 
28 Noorjahan 61 F 17123 Stress leak SUI NG Normal  TOT-Outsidein Improved 
29 Suseela 63 F 17298 Stress leak+UI MI NG Normal Leak demonstrared TOT-Outsidein Cured 
30 Backiyam 37 F 17689 Stress leak SUI NG Normal  TOT inside out Cured 
31 Geetha 30 F 894820 Stress leak+UI MI NG Normal Leak demonstrared TOT-Outsidein Improved 
32 Parvatham 43 F 895690 Stress leak SUI NG Normal  TOT inside out Cured 
33 Vani 46 F 896785 Stress leak+UI MI NG Normal Leak demonstrared TOT-Outsidein Cured 
 Sl 
No 
Name Age Sex IP No Presentation Diagnosis Urine  
c/s 
USG UDE Procedure Outcome 
34 Latha 40 F 897213 Stress leak SUI NG Normal  TOT-Outsidein Cured 
35 Shakilabanu 32 F 897779 Stress leak+UI MI NG Normal Leak demonstrared TOT inside out failed 
36 Anita 44 F 898654 Stress leak SUI NG Normal  TOT-Outsidein Improved 
37 Jenneth 41 F 898765 Stress leak SUI NG Normal  TOT inside out Cured 
38 Sangeetha 33 F 899345 Stress leak+UI MI Klebsiella Normal Leak demonstrared TOT-Outsidein Cured 
39 Nirmala 39 F 902345 Stress leak SUI NG Normal  TOT-Outsidein Cured 
40 Abirami 45 F 903786 Stress leak SUI NG Fibroid Uterus  TOT-Outsidein Improved 
41 Mangai 48 F 904378 Stress leak SUI NG Normal  TOT inside out Cured 
42 Mariammal 57 F 904987 Stress leak SUI NG Normal  TOT-Outsidein Cured 
43 Perumayammal 44 F 905615 Stress leak+UI MI NG Normal Leak demonstrared TOT inside out Cured 
44 Sridevi 35 F 906435 Stress leak SUI NG Normal  TOT inside out Cured 
45 Kalarani 40 F 907432 Stress leak+UI MI NG Normal Leak demonstrared TOT-Outsidein Cured 
46 Vijaya 43 F 907865 Stress leak SUI NG Normal  TOT inside out Cured 
47 Damayanthi 64 F 908234 Stress leak SUI NG Normal  TOT inside out Cured 
48 Shanmugapriya 61 F 909876 Stress leak SUI NG Normal  TOT-Outsidein failed 
49 Anuradha 47 F 912347 Stress leak SUI NG Normal  TOT inside out Cured 
50 Gokila 31 F 913678 Stress leak SUI NG Normal  TOT inside out Cured 
51 Priya 37 F 914589 Stress leak+UI MI NG Normal Leak demonstrared TOT-Outsidein Improved 
52 Sitalakshmi 41 F 914987 Stress leak SUI NG Normal  TOT-Outsidein Cured 
53 Shanthana lakshmi 50 F 915324 Stress leak SUI NG Normal  TOT inside out Cured 
54 Manimegalai 46 F 915786 Stress leak+UI MI NG Normal Leak demonstrared TOT-Outsidein Cured 
55 Kowsalya 43 F 916875 Stress leak SUI NG Normal  TOT inside out Cured 
56 Sharmila 54 F 917654 Stress leak+UI MI NG Normal Leak demonstrared TOT-Outsidein Cured 
57 Kalpana 61 F 918564 Stress leak SUI NG Normal  TOT inside out Cured 
58 Shifa 43 F 919765 Stress leak+UI MI NG Normal Leak demonstrared TOT-Outsidein Cured 
59 Jeyanthi 55 F 919876 Stress leak SUI NG Normal  TOT inside out Cured 
60 Mookkammal 63 F 921456 Stress leak SUI NG Normal  TOT-Outsidein Cured 
 
 
 
 
 
 PATIENT PROFORMA 
Age 20-30 
        31-40 
        41-50 
        51-60 
        >60 
Duration of symptoms 
         <3 months 
         4-12 months 
         1-3 years 
          >3 years 
Presenting complaint 
        Leakage with cough,sneeze, lifting heavy objects 
        Leakage with the desperate desire to void 
        Leakage without warning 
Frequency 
Urgency 
Nocturia 
Burning Micturition 
 Haematuria 
Strain to void 
Intermittent (stop-start) 
Flow is prolonged 
Post void dribble (Pt getsup from the toilet thinking she is empty but 
urine tricklesout as she walks away) 
Need to revoid 
History for prolopse uterus 
                  Something coming down in the vagina 
Anal incontinence if present for flatus or faeces 
Any duspareunia 
H/O Drug therapy 
     Alpha Blockers (provokes Stress Incontinence) 
     Diuretic therapy 
     Chronic Dry Cough with ACE inhibitor provoke SI 
     Psychotrophic Drugs (Lithium,Serotonin reuptake inhibitors) overflow 
incontinence 
Previous surgical history in related to incontinence 
History for bacterial cystitis 
           ->3 proven episodes of cystitis in last 5 years 
            -Any investigation to exclude stone  
           -cystoscopy 
History for Interstitial cystitis 
           -Supra pubic pain worse with full bladder, relieved by 
voiding,frequency 10 – 20 times,5-10 nocturia 
Co morbid conditions 
         COPD/Brochial Asthma 
         HT/Diuretics 
         Obesity 
Menstruating/Menopausal 
Obstetric Details 
         Duration of labour  Normal or prolonged 
         Weight of the baby <3 kg,3-4kg,>4 kg 
         Mode of delivery  Labour normal 
                                         LSCS after prolonged labour 
                                         LSCS  
PN complications  PPH 
                                  CPT 
 Frequency Volume Chart 
Date/Time Fluids takenin Amout of urine 
passed 
When you leak 
 
How bad is the problem 
 How often do you leak urine(All the time,daily,2-3 times 
weakly,weakly or less). 
 How much urine do you leak(A little bit,moderate amount,large 
amount). 
 How much does it affect your daily life(on a scale of 1-10)                                      
    Clinical Examination 
Abd 
Any mass that increase intra abd pressure may cause incontinence 
Inspection of vulva 
Healthy pink skin like appearance-pre menopausal women 
Shiny glistening red epithelium-Post menopausal atrophy 
Cracks or fissure like lesion bet labia majora &minora 
Urethral caruncle (indicates oestrogen deprivation)\ 
Any cystocele or Rectocele 
Perineum for signs of post obstetric perineal deficiency 
 Stress leak 
Part the labia and ask the patient to void 
Stress leak  -Short spurt of urine that occurs during the height of the 
cough effort 
Urge leak   - An instant after the cough but a large prolonged urine leak is 
seen due to detrusor contraction 
Speculum examination 
 Sims speculum examination 
 Bimanual examination, palpate the urethrae 
Pelvic Floor muscle Contraction 
                     Grading 0-Nil 
                                    1-Muscle on stretch-flicker 
                                    2-Week squeeze with 2 second hold 
                                    3-5 second hold 
                                    4-7 second hold 
                                    5-10 second hold 
PR 
Basic Neurological Examination 
 
 
